Pfizer Legal & Regulatory

Pfizer Board Meeting Date

Pfizer Limited has scheduled a board meeting for 3 November 2026 to consider unaudited standalone half-yearly results for the period ended September 2026. The trading window closes from 30 September 2026 until 5 November 2026.

Pfizer Other Announcement

Pfizer Ltd has filed its quarterly shareholding pattern as per SEBI regulations. This is a routine compliance disclosure.

Pfizer Management Change

Pfizer Limited announced the resignation of Mr. Sharad Goswami, Senior Director – Policy & Public Affairs, effective from the close of business on September 25, 2026.

Pfizer Board Meeting Outcome

Pfizer Board approved discontinuation of Minipress XL effective September 7, 2026. The company will receive ₹131.38 Crore lump-sum payment from Pfizer Inc., USA.

Value

₹131.4 Cr

Pfizer Annual General Meeting

Pfizer Limited held its 75th Annual General Meeting on July 28, 2026. The meeting covered the adoption of financial statements, dividend declaration, and auditor remuneration ratification.

Pfizer Q1 FY27 Results: Net Profit ₹204.5 Cr, Up 6.6% YoY

Pfizer Ltd reported revenue from operations of ₹653.2 Cr (+8.3% YoY) and net profit of ₹204.5 Cr (+6.6% YoY) for Q1 FY27.

Key figure

Net profit ₹204.5 Cr · +6.6% YoY

Coromandel International Legal & Regulatory

Coromandel International received a Deputy Commissioner (Appeal) GST order-in-appeal for FY 2019-20 confirming ineligible input tax credit demand. The company will appeal before GSTAT and expects no significant financial impact.

Value

₹0.18 Cr

Taurian Mps Legal & Regulatory

Taurian MPS received a SEBI adjudication order imposing penalties of Rs.5 lakh on the company, Rs.5 lakh on promoters jointly, and Rs.8 lakh on the merchant banker. The penalties relate to IPO offer document disclosure deficiencies.

Value

₹0.05 Cr

Coromandel International Legal & Regulatory

Coromandel International received a GST Order-in-Appeal confirming a ₹1.79 Crore tax demand. Including interest and penalty, the total is ₹4.05 Crore; the company will appeal.

Value

₹4.05 Cr

Shreeji Global FMCG Legal & Regulatory

Shreeji Global FMCG received a customs Order-in-Original demanding about ₹42.47 Crore in duty, penalties and redemption fines. The company plans to appeal before CESTAT.

Value

₹42.47 Cr

HD Fire Protect Legal & Regulatory

HD Fire Protect received an MPCB refusal of Consent to Operate for its Jalgaon expansion sheds. Existing manufacturing operations continue, with no material impact anticipated.

Krishna Institute of Medical Sciences Legal & Regulatory

KIMS discloses a pending suit over its Chennai hospital land lease, naming it defendant. Supreme Court dismissed its SLP; no injunction halts the project.